MADRIGAL PHARMACEUTICALS INC (MDGL) Stock Cash Flow
NASDAQ:MDGL • US5588681057
431.53 USD
-1.25 (-0.29%)
At close: Mar 11, 2026
431.53 USD
0 (0%)
After Hours: 3/11/2026, 8:10:19 PM
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -288.28M | -465.89M | -373.63M | -295.35M | -241.85M | |||
| Depreciation Amortization | 1.51M | 1.10M | 527.00K | 470.00K | 410.00K | |||
| Change In Working Capital | -8.50M | -72.34M | -3.28M | 37.60M | 30.65M | |||
| Other non cash items | 105.72M | 81.57M | 52.15M | 32.42M | 26.87M | |||
| OPERATING CASH FLOW | -189.55M | -455.57M | -324.23M | -224.86M | -183.92M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.47M | -6.46M | -1.48M | -220.00K | -210.00K | |||
| Other Investing Activity | 35.79M | -267.92M | -501.04M | 206.90M | -4.85M | |||
| INVESTING CASH FLOW | 32.32M | -274.39M | -502.52M | 206.69M | -5.06M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 228.34M | 0.00 | 65.00M | 50.00M | N/A | |||
| Stock Issued/Repurchased | 38.05M | 735.06M | 530.48M | 264.34M | 171.24M | |||
| Other Financing Activity | -10.41M | 0.00 | -363.00K | -890.00K | N/A | |||
| FINANCING CASH FLOW | 255.98M | 735.06M | 595.12M | 313.45M | 171.24M | |||
| Exchange Rate Effect | 13.00K | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | 98.76M | 5.10M | -231.63M | 295.28M | -17.74M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -189.55M | -455.57M | -324.23M | -224.86M | -183.92M | |||
| Capital Expenditure | -3.47M | -6.46M | -1.48M | -220.00K | -210.00K | |||
| FREE CASH FLOW | -193.02M | -462.03M | -325.71M | -225.08M | -184.13M | |||
All data in USD